journal article·2022-02-21Open access

Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential

Mike Wagenbrenner, Konrad Poker, Tizian Heinz, Marietta Herrmann, Konstantin Horas, Regina Ebert, Susanne Mayer-Wagner, Boris M. Holzapfel, Maximilian Rudert, Andre F. Steinert, Manuel Weißenberger

Applied Sciences· Volume 12· Issue 4

Abstract

(1) Background: The mesenchymal stromal cells (MSCs) of different tissue origins are applied in cell-based chondrogenic regeneration. However, there is a lack of comparability determining the most suitable cell source for the tissue engineering (TE) of cartilage. The purpose of this study was to compare the in vitro chondrogenic potential of MSC-like cells from different tissue sources (bone marrow, meniscus, anterior cruciate ligament, synovial membrane, and the infrapatellar fat pad removed during total knee arthroplasty (TKA)) and define which cell source is best suited for cartilage regeneration. (2) Methods: MSC-like cells were isolated from five donors and expanded using adherent monolayer cultures. Differentiation was induced by culture media containing specific growth factors. Transforming growth factor (TGF)-ß1 was used as the growth factor for chondrogenic differentiation. Osteogenesis and adipogenesis were induced in monolayer cultures for 27 days, while pellet cell cultures were used for chondrogenesis for 21 days. Control cultures were maintained under the same conditions. After, the differentiation period samples were analyzed, using histological and immunohistochemical staining, as well as molecularbiological analysis by RT-PCR, to assess the expression of specific marker genes. (3) Results: Plastic-adherent growth and in vitro trilineage differentiation capacity of all isolated cells were proven. Flow cytometry revealed the clear co-expression of surface markers CD44, CD73, CD90, and CD105 on all isolated cells. Adipogenesis was validated through the formation of lipid droplets, while osteogenesis was proven by the formation of calcium deposits within differentiated cell cultures. The formation of proteoglycans was observed during chondrogenesis in pellet cultures, with immunohistochemical staining revealing an increased relative gene expression of collagen type II. RT-PCR proved an elevated expression of specific marker genes after successful differentiation, with no significant differences regarding different cell source of native tissue. (4) Conclusions: Irrespective of the cell source of native tissue, all MSC-like cells showed multipotent differentiation potential in vitro. The multipotent differentiation capacity did not differ significantly, and chondrogenic differentiation was proven in all pellet cultures. Therefore, cell suitability for cell-based cartilage therapies and tissue engineering is given for various tissue origins that are routinely removed during total knee arthroplasty (TKA). This study might provide essential information for the clinical tool of cell harvesting, leading to more flexibility in cell availability.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, Germany

Department of General Surgery, Leopoldina Hospital of the City Schweinfurt, Gustav-Adolf-Str. 8, 97422 Schweinfurt, Germany

Department of General and Trauma Surgery, Main-Klinik Ochsenfurt, Am Greinberg 25, 97199 Ochsenfurt, Germany

Bernhard-Heine-Center for Locomotion Research, Department of Orthopedic, University of Würzburg, 97074 Würzburg, Germany

IZKF Research Group Tissue Regeneration in Musculoskeletal Diseases, University Hospital Würzburg, Röntgenring 11, 97070 Würzburg, Germany

Department of Orthopaedic Surgery, University of Würzburg, König-Ludwig-Haus, Brettreichstr. 11, 97074 Würzburg, Germany

Department of Orthopaedic, Trauma, Shoulder and Arthroplasty Surgery, Rhön-Klinikum Campus Bad Neustadt, Von-Guttenberg-Str. 11, 97616 Bad Neustadt, Germany

References (49)

Show source-provided references
1. Tissue Engineering; Current Status & Futuristic Scope10.25122/jml-2019-0032 ↗
2. Use of Adult Stem Cells for Cartilage Tissue Engineering: Current Status and Future Developments10.1155/2015/438026 ↗
3. Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine10.1155/2018/2495848 ↗
4. Jessop, Z., Al-Sabah, A., Francis, W.R., and Whitaker, I.S. (2016). Transforming healthcare through regenerative medicine. BMC Med., 14.10.1186/s12916-016-0669-4 ↗
5. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review10.18295/squmj.2018.18.03.002 ↗
6. Keeping kidneys10.2471/BLT.12.021012 ↗
7. Treatment of Articular Cartilage Defects: Focus on Tissue Engineering10.21873/invivo.11379 ↗
8. (2019). Health at a Glance 2019 OECD Indicators: OECD Indicators, OECD Publishing.
9. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years
10. Total hip arthroplasty: Survival and modes of failure10.1302/2058-5241.3.170068 ↗
11. Survival analysis of total knee arthroplasty at a minimum 10 years’ follow-up: A multicenter French nationwide study including 846 cases10.1016/j.otsr.2013.03.014 ↗
12. Incidence and short-term outcomes of primary and revision hip replacement in the United States10.2106/00004623-200703000-00009 ↗
13. Causes and Clinical Outcomes of Revision Total Knee Arthroplasty10.5792/ksrr.16.035 ↗
14. Tissue Engineering in Osteoarthritis: Current Status and Prospect of Mesenchymal Stem Cell Therapy10.1007/s40259-018-0276-3 ↗
15. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement10.1080/14653240500319234 ↗
16. Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., and Ding, J. (2019). Mesenchymal Stem Cells for Regenerative Medicine. Cells, 8.10.3390/cells8080886 ↗
17. Major biological obstacles for persistent cell-based regeneration of articular cartilage10.1186/ar2195 ↗
18. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source10.1002/art.21212 ↗
19. Wagenbrenner, M., Heinz, T., Horas, K., Jakuscheit, A., Arnholdt, J., Herrmann, M., Rudert, M., Holzapfel, B.M., Steinert, A.F., and Weißenberger, M. (2020). The human arthritic hip joint is a source of mesenchymal stromal cells (MSCs) with extensive multipotent differentiation potential. BMC Musculoskelet Disord., 21.10.1186/s12891-020-03340-z ↗
20. Human Mesenchymal Stromal Cells from Different Sources Diverge in Their Expression of Cell Surface Proteins and Display Distinct Differentiation Patterns10.1155/2016/5646384 ↗
21. Isolation, Characterization, and Multipotent Differentiation of Mesenchymal Stem Cells Derived from Meniscal Debris10.1155/2016/5093725 ↗
22. Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells10.1089/ten.tea.2010.0413 ↗
23. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer10.1186/ar2822 ↗
24. Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of human mesenchymal stem cells10.1186/scrt316 ↗
25. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells10.1016/S0736-0266(02)00018-9 ↗
26. Characterization of bursa subacromialis-derived mesenchymal stem cells10.1186/s13287-015-0104-3 ↗
27. The expression of marker genes during the differentiation of mesenchymal stromal cells10.17219/acem/68386 ↗
28. Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity10.1177/0363546517729152 ↗
29. The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications
30. Sources of adult mesenchymal stem cells applicable for musculoskeletal applications—A systematic review of the literature10.2174/1874325001105010242 ↗
31. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
32. Bone marrow mesenchymal stem cells: Historical overview and concepts10.1089/hum.2010.115 ↗
33. Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage10.1186/ar3320 ↗
34. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage10.1002/art.20269 ↗
35. Isolation and Characterization of Synovial Mesenchymal Stem Cell Derived from Hip Joints: A Comparative Analysis with a Matched Control Knee Group10.1155/2017/9312329 ↗
36. Multipotent mesenchymal stem cells from adult human synovial membrane10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P ↗
37. Synovial membrane mesenchymal stem cells: Past life, current situation, and application in bone and joint diseases10.1186/s13287-020-01885-3 ↗
38. The infrapatellar fat pad and the synovial membrane: An anatomo-functional unit10.1111/joa.12820 ↗
39. Infrapatellar Fat Pad-Derived Stem Cell-Based Regenerative Strategies in Orthopedic Surgery10.5792/ksrr.17.061 ↗
40. Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament10.1080/14653240802474323 ↗
41. Isolation and characterization of multipotent stem cells from human cruciate ligaments10.1111/j.1365-2184.2009.00611.x ↗
42. Sheng, G. (2015). The developmental basis of mesenchymal stem/stromal cells (MSCs). BMC Dev. Biol., 15.10.1186/s12861-015-0094-5 ↗
43. Mesenchymal Stem Cells: Time to Change the Name!10.1002/sctm.17-0051 ↗
44. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles10.1002/jor.20786 ↗
45. Characterisation of synovial fluid and infrapatellar fat pad derived mesenchymal stromal cells: The influence of tissue source and inflammatory stimulus10.1038/srep24295 ↗
46. Early results of intra-articular micro-fragmented lipoaspirate treatment in patients with late stages knee osteoarthritis: A prospective study10.3325/cmj.2019.60.227 ↗
47. Adipose-derived mesenchymal stem cells for cartilage tissue engineering: State-of-the-art in in vivo studies10.1002/jbm.a.34896 ↗
48. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: Applications in cartilage repair and osteoarthritis therapy
49. Aging of mesenchymal stem cells: Implication in regenerative medicine10.1016/j.reth.2018.09.002 ↗